Patent EP0072462A2 successfully refreshed from Google Patents.
EP0072462A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Pharmaceutical preparations
Assignee: Toko Yakuhin Kogyo KK
•
Filing: 1982-07-27
•
Granted: —
•
Expires: 2002-07-27
Abstract
Abstract A pharmaceutical preparation for external use which comprises a solution of a non-steroid antipholgistic analgesic agent which is dissolved in at least one adjuvant selected from the group consisting of peppermint oil, methyl salicylate, ethyl salicylate and monoglycol salicylate in an amount at least sufficient to dissolve said antipholgistic analgesic . agent, and bases for external use.
Inventors
- 👤 Takuzo Kamashita
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-07 21:09
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0014; A61K47/00; A61K47/06; A61K47/08; A61K47/14; A61K47/44; A61P; A61P25/00; A61P25/04; A61P29/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
70 words
A pharmaceutical preparation for external use which comprises a solution of a non-steroid compound having an acetic acid or propionic acid group in the molecule and an antiphlogistic or analgesic activity which is dissolved in at least one adjuvant selected from the group consisting of peppermint oil,methyl salicylate, ethyl salicylate and monoglycol salicylate in an amount at least sufficient for dissolving said non-steroid compound, and a base for external use.
Claim 2
Dependent Claim
70 words
A pharmaceutical preparation for external use which comprises a solution of a non-steroid compound having an acetic acid or propionic acid group in the molecule and an antiphlogistic or analgesic activity which is dissolved in at least one adjuvant selected from the group consisting of peppermint oil,methyl salicylate, ethyl salicylate and monoglycol salicylate in an amount at least sufficient for dissolving said non-steroid compound, and a base for external use.
Claim 3
Dependent Claim
43 words
A pharmaceutical preparation according to claim 1 wherein the non-steroid compound is ibuprofen, ketoprofen, flurbiprofen, naproxen, benoxaprofen, pranoprofen, suprofen, fenoprofen, Y-9213 [2-{4-[-imidazo-(1,2-a)-pyridyl} propionic acid], tiaprofenic acid, protizinic acid, ibufenac, alclofenac, metiazinic acid, suxibuzone, oxepinac, sulindac, fentiazac, indomethacin, diclofenac, bendazac, zomepirac, tolmetin or fenbufen.
Claim 4
Dependent Claim
20 words
A pharmaceutical preparation according to claim 1 or 2 which contains 0.5 - 3.0 w/w % of the non-steroid compound.
Claim 5
Dependent Claim
27 words
A pharmaceutical preparation according to claim 1 wherein the ratio by weight of peppermint oil to the non-steroid compound is 1 - 10 parts : 1 part.
Claim 6
Dependent Claim
27 words
A pharmaceutical preparation according to claim 4 wherein the ratio by weight of peppermint oil to the non-steroid compound is 2 - 8 parts : 1 part.
Claim 7
Dependent Claim
30 words
A pharmaceutical preparation according to claim 1 wherein the ratio by weight of methyl salicylate or ethyl salicylate to the non-steroid compound is 5 - 16 parts : 1 part.
Claim 8
Dependent Claim
27 words
A pharmaceutical preparation according to claim 1 wherein the ratio by weight of monoglycol salicylate to the non-steroid compound is 3 - 8 parts : 1 part.
Claim 9
Dependent Claim
42 words
A pharmaceutical preparation according to claim 1 wherein the ratio by weight of peppermint oil and one selected from the group consisting of methyl salicylate, ethyl salicylate and monoglycol salicylate to the non-steroid compound is 3 - 16 parts : 1 part.
Claim 10
Dependent Claim
17 words
A pharmaceutical preparation according to-claim 1 which is in a gel, gel cream, cream or poultice form.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.